• Explore /
  • Poster
  • / German Adjuvant Intergroup Node Positive (GAIN) study: A phase III trial to compare IDD-ETC versus EC-TX in patients with node-positive primary breast cancer—Final efficacy analysis.

German Adjuvant Intergroup Node Positive (GAIN) study: A phase III trial to compare IDD-ETC versus EC-TX in patients with node-positive primary breast cancer—Final efficacy analysis.

Abstract Poster

Authors

null

Volker Jochen Moebus

Klinikum Frankfurt Hoechst, Frankfurt, Germany

Volker Jochen Moebus , Gunter Von Minckwitz , Christian Jackisch , Hans-Joachim Lueck , Andreas Schneeweiss , Hans Tesch , Dirk Elling , Nadia Harbeck , Bettina Conrad , Tanja Fehm , Jens Bodo Huober , Volkmar Müller , Ingo Bauerfeind , Marcus Schmidt , Sibylle Loibl , Valentina Nekljudova , Michael Untch , Christoph Thomssen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Highlights Session

Session Title

Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Cytotoxic Chemotherapy

Clinical Trial Registration Number

NCT 001 968 72

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 1009)

DOI

10.1200/jco.2014.32.15_suppl.1009

Abstract #

1009

Poster Bd #

1

Abstract Disclosures

Similar Posters

First Author: Begoña Bermejo

First Author: Alexios Matikas

First Author: Ralph V. Boccia

First Author: Karen A. Gelmon